NCT04877314

Brief Summary

Positive effects of calorie restriction on quality of life and diseases are reported. Intermittent fasting, one of the calorie restriction methods, has been shown to be beneficial for health with many metabolic effects, not just calorie restriction. Preclinical studies show the disease-modifying effects of intermittent fasting in animal models on a wide variety of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases. There are very few studies evaluating the effects of intermittent fasting on the immune system, and only TNFα, IL6 and IL10 cytokines were evaluated in these studies to evaluate the immune system. In this study, we aimed to evaluate the conditions of inflammatory markers in peripheral blood before and after intermittent fasting period in overweight volunteers with a Body Mass Index between 25 and 30. Volunteers will have intermittent fasting for 3 weeks, which conforms to the 16-hour fasting and 8-hour meal format.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

June 2, 2022

Status Verified

June 1, 2022

Enrollment Period

22 days

First QC Date

May 5, 2021

Last Update Submit

June 1, 2022

Conditions

Keywords

CytokineIntermittent fasting

Outcome Measures

Primary Outcomes (1)

  • Cytokine levels

    IL1, IL6, TNFα, IL10 cytokine levels

    3 weeks

Secondary Outcomes (1)

  • Demographic values

    3 weeks

Study Arms (1)

Intermittent fasting

EXPERIMENTAL
Other: Intermittent fasting

Interventions

30 overweight male volunteers who will have 3 weeks intermittent fasting which has 16 hours fasting and 8 hours eating in a day period.

Intermittent fasting

Eligibility Criteria

Age18 Years - 80 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsHormonal factors could affect cytokine values over time
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bady mass index should be between 25-30
  • Male

You may not qualify if:

  • Diabetes patients,
  • Immune deficiency history,
  • Cancer patients,
  • Individuals who did not agree to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Training and Research Hospital

Istanbul, 34098, Turkey (Türkiye)

Location

Related Publications (3)

  • Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1997 Oct 2;337(14):986-94. doi: 10.1056/NEJM199710023371407. No abstract available.

    PMID: 9309105BACKGROUND
  • Panda S. Circadian physiology of metabolism. Science. 2016 Nov 25;354(6315):1008-1015. doi: 10.1126/science.aah4967.

    PMID: 27885007BACKGROUND
  • Di Francesco A, Di Germanio C, Bernier M, de Cabo R. A time to fast. Science. 2018 Nov 16;362(6416):770-775. doi: 10.1126/science.aau2095.

    PMID: 30442801BACKGROUND

MeSH Terms

Conditions

Intermittent Fasting

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Study Officials

  • Ufuk O Idiz, Assoc.Prof.

    Istanbul Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Measuring the level of IL1, IL6, TNFα, IL10 cytokines before and after the 3 weeks intermittent fasting period for 30 overweight volunteers
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Cytokine levels before and after intermittent fasting period for 3 weeks
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. MD

Study Record Dates

First Submitted

May 5, 2021

First Posted

May 7, 2021

Study Start

April 13, 2021

Primary Completion

May 5, 2021

Study Completion

June 15, 2021

Last Updated

June 2, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

If the study complete, we could share

Locations